News

SCOTUSblog6h
Justices reject challenge to structure of HHS task force that supported providing coverage for HIV medication
The Supreme Court on Friday rejected a challenge to the structure of a Department of Health and Human Services task force ...
By maintaining Obamacare pillar, Supreme Court hands win to HIV advocates
The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
KTVU FOX 2 on MSN9d
New HIV prevention drug introduced, but it comes at a high cost
As with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug ...
Public Broadcasting Service (PBS)7d
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
KUNC3d
FDA approves HIV medication Lenacapavir, but it's costly
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report
Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...
FDA Approves ‘Breakthough’ Drug to Prevent HIV
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
Daily Monitor9d
New HIV prevention drug to cost Shs102m | Monitor
The drug is coming at a time when several studies aimed at finding an HIV cure or vaccine failed to yield expected results, even as the world races to end HIV/AIDs as a public health threat by 2030.